Brian P. Chan

State Key Laboratory For Emerging Infectious Diseases, Pokfulam, Hong Kong Special Administrative Region
Lika, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Concurrent comparison of severity of influenza and coronavirus disease 2019 among hospitalized patients in Hong Kong: a target trial emulation on observational health care data.

Concurrent comparison of severity of influenza and coronavirus disease 2019 among hospitalized patients in Hong Kong: a target trial emulation on observational health care data.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: March 17, 2026

Risk assessment of 2024 cattle H5N1 using age-stratified serosurveillance data.

Risk assessment of 2024 cattle H5N1 using age-stratified serosurveillance data.

Journal: Emerging microbes & infections

Published: April 22, 2025

Corrigendum to "The significance of recurrent de novo amino acid substitutions that emerged during chronic SARS-CoV-2 infection: an observational study" [eBioMedicine, 2024;107:105273].

Corrigendum to "The significance of recurrent de novo amino acid substitutions that emerged during chronic SARS-CoV-2 infection: an observational study" [eBioMedicine, 2024;107:105273].

Journal: EBioMedicine

Published: September 25, 2024

The impact of vaccine type and booster dose on the magnitude and breadth of SARS-CoV-2-specific systemic and mucosal antibodies among COVID-19 vaccine recipients.

The impact of vaccine type and booster dose on the magnitude and breadth of SARS-CoV-2-specific systemic and mucosal antibodies among COVID-19 vaccine recipients.

Journal: Heliyon

Published: May 07, 2024

The significance of recurrent de novo amino acid substitutions that emerged during chronic SARS-CoV-2 infection: an observational study.

The significance of recurrent de novo amino acid substitutions that emerged during chronic SARS-CoV-2 infection: an observational study.

Journal: EBioMedicine

Published: January 25, 2024

Characterizing fitness and immune escape of SARS-CoV-2 EG.5 sublineage using elderly serum and nasal organoid.

Characterizing fitness and immune escape of SARS-CoV-2 EG.5 sublineage using elderly serum and nasal organoid.

Journal: iScience

Published: December 01, 2023

Humoral and cellular immunity against different SARS-CoV-2 variants in patients with chronic kidney disease.

Humoral and cellular immunity against different SARS-CoV-2 variants in patients with chronic kidney disease.

Journal: Scientific reports

Published: August 11, 2023

Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross sectional study.

Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross sectional study.

Journal: EBioMedicine

Published: September 30, 2022

SARS-CoV-2 IgG seropositivity after the severe Omicron wave of COVID-19 in Hong Kong.

SARS-CoV-2 IgG seropositivity after the severe Omicron wave of COVID-19 in Hong Kong.

Journal: Emerging microbes & infections

Published: July 26, 2022

Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong.

Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong.

Journal: Nature communications

Published: April 01, 2022

Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines.

Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines.

Journal: EBioMedicine

Published: February 07, 2022

Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine.

Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine.

Journal: Emerging microbes & infections

Published: January 27, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026